DIN 02494574 — CLADRIBINE INJECTION 1 MG
CLADRIBINE INJECTION is a solution of Cladribine marketed by GENERIC MEDICAL PARTNERS INC. The full Cladribine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02494574
- Brand name
- CLADRIBINE INJECTION
- Active ingredient
- Cladribine
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- GENERIC MEDICAL PARTNERS INC
- Health Canada status
- MARKETED
- Drug class
- Selective immunosuppressant (purine nucleoside analogue)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Cladribine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02553295 | APO-CLADRIBINE | 10 MG | TABLET | APOTEX INC | MARKETED |
| 02566443 | AURO-CLADRIBINE | 10 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02319918 | CLADRIBINE INJECTION | 1 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02470179 | MAVENCLAD | 10 MG | TABLET | EMD SERONO, A DIVISION OF EMD INC., CANADA | MARKETED |